- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: The Open Respiratory Medicine Journal, 6, 1, S. 63-74
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2012
- Ereignis
-
Veröffentlichung
- (wo)
-
Sharjah [u.a.]
- (wer)
-
Bentham Open
- (wann)
-
2012
- Urheber
-
Schwaiblmair, Martin
Behr, Werner
Haeckel, Thomas
Märkl, Bruno
Foerg, Wolfgang
Berghaus, Thomas
- DOI
-
10.2174/1874306401206010063
- URN
-
urn:nbn:de:bvb:384-opus4-571668
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schwaiblmair, Martin
- Behr, Werner
- Haeckel, Thomas
- Märkl, Bruno
- Foerg, Wolfgang
- Berghaus, Thomas
- Universität Augsburg
- Bentham Open
Entstanden
- 2012
Ähnliche Objekte (12)
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
Immunotherapy-induced interstitial lung disease: Cases report
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease
Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease
Respiratory bronchiolitis-interstitial lung disease
Clinical and radiological pattern of olaparib-induced interstitial lung disease
Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease
Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database
Clinical Atlas of Interstitial Lung Disease
Progression of fibrosing interstitial lung disease
Comorbidities in unclassifiable interstitial lung disease
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
Immunotherapy-induced interstitial lung disease: Cases report
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease
Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease
Respiratory bronchiolitis-interstitial lung disease
Clinical and radiological pattern of olaparib-induced interstitial lung disease
Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease
Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database
Clinical Atlas of Interstitial Lung Disease
Progression of fibrosing interstitial lung disease
Comorbidities in unclassifiable interstitial lung disease
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
Immunotherapy-induced interstitial lung disease: Cases report
Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease
Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease
Respiratory bronchiolitis-interstitial lung disease
Clinical and radiological pattern of olaparib-induced interstitial lung disease
Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease
Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database
Clinical Atlas of Interstitial Lung Disease
Progression of fibrosing interstitial lung disease